ENUMERAL Assay Development. ENUMERAL will develop a * screening assay on its microengraved * array platform using SANOFI US provided materials and other materials as appropriate, and use the screening array with the goal of identifying *. Cells will be screened by ENUMERAL using a * method consisting of the following steps: 5. When the above assays are established, ENUMERAL will conduct assays to demonstrate selectivity and affinity ranking results of the sanofi * antibodies * Reagents required that will be supplied by ENUMERAL · * · * · * · Stains for in-well cytometry o * o * o * o * · Poly L slides · Microwell devices · Media for hybridomas · Equipment and reagents for processing of devices and slides for generation of cytometry data and printed arrays
Appears in 3 contracts
Sources: Research Agreement (Enumeral Biomedical Holdings, Inc.), Research Agreement (Enumeral Biomedical Holdings, Inc.), Research Agreement (Enumeral Biomedical Holdings, Inc.)